
Sign up to save your podcasts
Or


In this episode of the podcast, Joe interviews Greg McKee: Chairman and CEO of Tryp Therapeutics, an early-stage biotech company researching the use of psilocybin derivatives to alleviate nociplastic pain like fibromyalgia.
www.psychedelicstoday.com
By Psychedelics Today4.6
553553 ratings
In this episode of the podcast, Joe interviews Greg McKee: Chairman and CEO of Tryp Therapeutics, an early-stage biotech company researching the use of psilocybin derivatives to alleviate nociplastic pain like fibromyalgia.
www.psychedelicstoday.com

819 Listeners

1,853 Listeners

2,621 Listeners

1,492 Listeners

640 Listeners

1,288 Listeners

1,022 Listeners

311 Listeners

1,045 Listeners

489 Listeners

186 Listeners

282 Listeners

115 Listeners

112 Listeners

148 Listeners